Table 1.
Author | Year | Group | Sample size | Age (years) | Sex (M/F) | Weight (kg) | Mode | Bolus (mg kg−1) | Infusion (μg kg−1 min−1) | Dose in IV-PCA(mg ml−1) | Timing | Postoperative Opioid | Control | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Javery | 1996 | Ketamine | 22 | 37.3 | ± | 9.9 | 18/4 | 78.2 | ± | 13.1 | IV-PCA | 1.0 | Postoperative | Morphine | Basic | ||
Control | 20 | 39.5 | ± | 7.2 | 18/2 | 83.9 | ± | 10.7 | |||||||||
| |||||||||||||||||
Sahin | 2004 | Ketamine | 17 | 46.5 | ± | 7.3 | 9/8 | 80.4 | ± | 16.1 | B | 0.5 | Intraoperative | Morphine | Saline | ||
Control | 14 | 46.1 | ± | 13.3 | 8/6 | 78.7 | ± | 13.2 | |||||||||
| |||||||||||||||||
Aveline | 2006 | Ketamine | 23 | 48.3 | ± | 12.3 | 11/12 | 74.2 | ± | 6.3 | B | 0.15 | Intraoperative | Morphine | Basic | ||
Control | 23 | 44.4 | ± | 11.2 | 10/13 | 68.4 | ± | 12.8 | |||||||||
| |||||||||||||||||
Engelhardt | 2008 | Ketamine | 16 | 14.8 | ± | 1.7 | 2/14 | 59.3 | ± | 16.5 | B+ivgtt | 0.5 | 4.0 | Intraoperative | Morphine | Saline | |
Control | 18 | 15.5 | ± | 1.2 | 3/15 | 56.5 | ± | 10.4 | |||||||||
| |||||||||||||||||
Moustafa | 2008 | Ketamine | 16 | 13.1 | ± | 5.08 | 7/9 | 39.7 | ± | 8.63 | ivgtt | 1.0 | Intraoperative | Morphine | Basic | ||
Control | 16 | 12.8 | ± | 6.07 | 6/10 | 34.6 | ± | 9.68 | |||||||||
| |||||||||||||||||
Urban | 2008 | Ketamine | 12 | 53 | ± | 12 | 80 | ± | 19 | B+ivgtt | 0.2 | 0.03 | Intraoperative Postoperative |
Hydromorphone | Saline | ||
Control | 12 | 48 | ± | 9 | 78 | ± | 19 | ||||||||||
| |||||||||||||||||
Hadi | 2009 | Ketamine | 20 | 22 | ± | 2 | 7/13 | 55 | ± | 15 | ivgtt | 1.0 | Intraoperative | Morphine | Basic | ||
Control | 20 | 21 | ± | 2 | 8/12 | 54 | ± | 13 | |||||||||
| |||||||||||||||||
Hadi | 2010 | Ketamine | 15 | 56.1 | ± | 10.5 | 7/8 | 66 | ± | 13 | ivgtt | 1.0 | Intraoperative | Morphine | Saline | ||
Control | 15 | 53.5 | ± | 10.2 | 3/12 | 68 | ± | 12 | |||||||||
| |||||||||||||||||
Loftus | 2010 | Ketamine | 52 | 51.7 | ± | 14.2 | 33/19 | 95.4 | ± | 17.7 | B+ivgtt | 0.5 | 10.0 | Intraoperative | Morphine | Saline | |
Control | 50 | 51.4 | ± | 14.4 | 28/22 | 89.3 | ± | 23.8 | |||||||||
| |||||||||||||||||
Subramaniam | 2011 | Ketamine | 15 | 57.2 | ± | 12.2 | 8/7 | 86.2 | ± | 24.4 | B+ivgtt | 0.15 | 2.0 | Intraoperative Postoperative |
Hydromorphone | Saline | |
Control | 15 | 56.5 | ± | 13.6 | 7/8 | 81.4 | ± | 19.2 | |||||||||
| |||||||||||||||||
Abrishamkar | 2012 | Ketamine | 22 | 49 | ± | 1.32 | 5/18 | ivgtt | 8.33 | Postoperative | Morphine | Basic | |||||
Control | 23 | 45 | ± | 1.64 | 10/12 | ||||||||||||
| |||||||||||||||||
Pacreu | 2012 | Ketamine | 10 | 52.9 | ± | 12.6 | 3/7 | 69.5 | ± | 7.2 | B+ivgtt+IV-PCA | 0.5 | 2.5 | 0.5 | Intraoperative Postoperative |
Methadone | Saline |
Control | 10 | 61.3 | ± | 11.7 | 3/7 | 75.9 | ± | 9.8 | |||||||||
| |||||||||||||||||
Yeom | 2012 | Ketamine | 20 | 61.0 | ± | 10.0 | 5/15 | 59.1 | ± | 13.5 | B+ivgtt | 0.2 | 0.5 | Intraoperative Postoperative |
Fentanyl | Saline | |
Control | 20 | 64.5 | ± | 11.5 | 7/13 | 64.8 | ± | 10.6 | |||||||||
| |||||||||||||||||
Hadi | 2013 | Ketamine | 30 | 55 | ± | 2.5 | 13/17 | 70 | ± | 2.5 | ivgtt | 1.0 | Intraoperative Postoperative |
Morphine | Saline | ||
Control | 15 | 51 | ± | 2.5 | 8/7 | 71 | ± | 2.6 | |||||||||
| |||||||||||||||||
Kim | 2013 | Ketamine | 35 | 56 | ± | 9.5 | 15/20 | 63.4 | ± | 10.5 | B+ivgtt | 0.5 | 1.0-2.0 | Intraoperative Postoperative |
Fentanyl | Saline | |
Control | 17 | 56 | ± | 13 | 9/8 | 66 | ± | 13 | |||||||||
| |||||||||||||||||
Song | 2013 | Ketamine | 24 | 52.3 | ± | 8.8 | 0/24 | 59 | ± | 7 | B+ivgtt | 0.3 | 0.04 | Intraoperative Postoperative |
Fentanyl | Saline | |
Control | 25 | 53.8 | ± | 7.8 | 0/25 | 60 | ± | 10 | |||||||||
| |||||||||||||||||
Pestieau | 2014 | Ketamine | 29 | 14.3 | ± | 1.8 | 5/24 | 60 | ± | 18 | B+ivgtt | 0.5 | 0.1-0.2 | Intraoperative Postoperative |
Morphine | Saline | |
Control | 21 | 14.5 | ± | 1.5 | 7/14 | 59 | ± | 14 | |||||||||
| |||||||||||||||||
Minoshima | 2015 | Ketamine | 17 | 15 | ± | 2 | 1/16 | 45 | ± | 6 | B+ivgtt | 0.5 | 2.0 | Intraoperative Postoperative |
Morphine | Saline | |
Control | 19 | 14 | ± | 2 | 0/19 | 46 | ± | 4 | |||||||||
| |||||||||||||||||
Garg | 2016 | Ketamine | 22 | 36.5 | ± | 13.4 | 13/9 | 61.5 | ± | 14.6 | B+ivgtt | 0.25 | 4.2 | Postoperative | Morphine | Saline | |
Control | 22 | 36.3 | ± | 14.3 | 16/6 | 65.3 | ± | 15.5 | |||||||||
| |||||||||||||||||
Mitra | 2017 | Ketamine | 14 | 33.9 | ± | 17.2 | 7/7 | 56.4 | ± | 10.1 | B+ivgtt | 0.5 | 4.2 | Intraoperative | Fentanyl | Saline | |
Control | 14 | 33.5 | ± | 15.2 | 6/8 | 57.9 | ± | 11.3 | |||||||||
| |||||||||||||||||
Nielsen | 2017 | Ketamine | 74 | 57 | ± | 14 | 28/46 | 77 | ± | 14 | B+ivgtt | 0.5 | 4.2 | Intraoperative | Morphine | Saline | |
Control | 73 | 55 | ± | 13 | 21/52 | 78 | ± | 18 | |||||||||
| |||||||||||||||||
Perello ´ | 2017 | Ketamine | 21 | 14.3 | ± | 1.9 | 5/16 | 54.3 | ± | 10.8 | B+ivgtt | 0.5 | 2.0 | Intraoperative Postoperative |
Morphine | Saline | |
Control | 23 | 14.3 | ± | 1.8 | 6/17 | 57.6 | ± | 12.6 | |||||||||
| |||||||||||||||||
Boenigk | 2018 | Ketamine | 49 | 54.5 | ± | 13.4 | 24/25 | 78.5 | ± | 7.2 | B+ivgtt | 0.2 | 2 | Postoperative | Hydromorphone | Saline | |
Control | 62 | 55.7 | ± | 13.2 | 29/33 | 85.4 | ± | 11.5 | |||||||||
| |||||||||||||||||
Czarnetzki | 2019 | Ketamine | 80 | 65.8 | ± | 13.8 | 39/41 | 79.8 | ± | 4.3 | B+ivgtt | 0.25 | 1.67-4.17 | Intraoperative Postoperative |
Morphine | Saline | |
Control | 80 | 65.6 | ± | 12.6 | 42/38 | 79.7 | ± | 3.4 | |||||||||
| |||||||||||||||||
Brinck | 2020 | Ketamine | 127 | 54.2 | ± | 13.2 | 40/87 | 76 | ± | 14 | B+ivgtt | 0.5 | 2-10 | Intraoperative | Oxycodone | Saline | |
Control | 62 | 55.5 | ± | 12 | 26/36 | 79 | ± | 15 | |||||||||
| |||||||||||||||||
Ricciardelli | 2020 | Ketamine | 24 | 13.4 | ± | 1.7 | 2/22 | 60.9 | ± | 17.4 | B+ivgtt | 0.5 | 3.33 | Intraoperative Postoperative |
Morphine | Saline | |
Control | 25 | 14.7 | ± | 2.2 | 8/17 | 61.6 | ± | 14.2 | |||||||||
| |||||||||||||||||
Andleeb | 2021 | Ketamine | 30 | 43.8 | ± | 14.6 | 15/15 | 57.4 | ± | 11.4 | ivgtt | 8.33 | Intraoperative | Morphine | Saline | ||
Control | 30 | 39.8 | ± | 14.1 | 14/16 | 58 | ± | 12.7 | |||||||||
| |||||||||||||||||
Brinck | 2021 | Ketamine | 75 | 60 | ± | 13.5 | 41/34 | 77.1 | ± | 14.5 | IV-PCA | 0.25-0.75 | Postoperative | Oxycodone | Saline | ||
Control | 25 | 56 | ± | 11 | 14/11 | 77.7 | ± | 15.6 | |||||||||
| |||||||||||||||||
Murphy | 2021 | Ketamine | 66 | 59.3 | ± | 16.4 | 32/34 | 64 | ± | 11 | ivgtt | 1.67-5.00 | Intraoperative Postoperative |
Hydromorphone | Saline | ||
Control | 61 | 65.3 | ± | 10.6 | 27/34 | 62 | ± | 11 | |||||||||
| |||||||||||||||||
Nikoubakht | 2021 | Ketamine | 29 | 52.8 | ± | 12.2 | 17/12 | ivgtt | 1.67 | Intraoperative | Morphine | Saline | |||||
Control | 29 | 53.8 | ± | 13.9 | 18/11 |
B indicates intravenous bolus; ivgtt, intravenously guttae; IV-PCA, intravenous patient-controlled analgesia.